Jamjoom Pharmaceuticals Factory Company (4015.SR) SAU
150.60
+6.2(+4.29%)
Currency In SAR
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 10B |
| Enterprise Value | 10B |
| P/E Ratio | 22.11 |
| PEG Ratio | 5.43 |
| Price/Sales Ratio | 7.02 |
| Price/Book Ratio | 6.21 |
| Enterprise/Revenue | 6.91 |
| Enterprise/EBITDA | 20.27 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
Profitability
| Profit Margin | 0.31 |
| Operating Margin | 0.32 |
Management Effectiveness
| Return On Assets | 0.23 |
| Return On Equity | 0.29 |
Income Statement
| Revenue | 1.5B |
| Revenue/Share | 22.04 |
| Gross Profit | 938.8M |
| EBITDA | 474.8M |
| Net Income | 463.8M |
| Diluted EPS | 6.6 |
Balance Sheet
| Total Cash | 169.7M |
| Total Cash/Share | 2.49 |
| Total Debt | 4.08M |
| Total Debt/Equity | 0 |
| Current Ratio | 4.18 |
| Book Value Per Share | 24.27 |
Price History
| 52-Week Change | 0.13 |
| 52-Week High | 183.8 |
| 52-Week Low | 125 |
| Moving Average 50 Days | 137.09 |
| Moving Average 200 Days | 151.15 |
Statistics
| Average Volume | 119,468 |
| Shares Outstanding | 70M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 4 |
| Trailing Annual Dividend Yield | 2.66 |
| Payout Ratio | 0.52 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
